Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13,080,549
-
Total 13F shares
-
2,974,685
-
Share change
-
+1,101,558
-
Total reported value
-
$37,573,341
-
Price per share
-
$12.65
-
Number of holders
-
24
-
Value change
-
+$13,805,081
-
Number of buys
-
13
-
Number of sells
-
13
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q3 2014
As of 30 Sep 2014,
EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,974,685 shares.
The largest 10 holders included
JENNISON ASSOCIATES LLC, Park West Asset Management LLC, Cormorant Asset Management, LLC, DEERFIELD MANAGEMENT CO, WALL STREET ASSOCIATES, Allianz Asset Management AG, CAM Group Holding A/S, Stanley-Laman Group, Ltd., FARALLON CAPITAL MANAGEMENT LLC, and NUMERIC INVESTORS LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.